Simón

Simón LÓpez RamÍrez, Mexico City MX

Patent application number	Description	Published
20110138683	Gemini surfactants, process of manufacture and use as multifunctional corrosion inhibitors - The disclosure relates to new surfactants of bis-N-alkyl polyether, bis-N-alkenyl polyether, bis-N-cycloalkyl polyether, bis-N-aryl polyether bis-beta or alpha-imino acids or their salts, process for obtaining and using mainly as multifunctional corrosion inhibitors, which protect and prevent corrosion of ferrous metals exposed to acidic, basic and neutral when transporting or storing crude oil and liquid fuels, or to the equipment and pipes used in cooling systems industry petroleum and petrochemical industries. Gemini surfactants have the structural formula:	06-16-2011
20130296200	COMPOSITION BASED ON GEMINALS ZWITTERIONICS LIQUIDS AS WETTABILITY MODIFIERS IN ENHANCED OIL RECOVERY PROCESSES - The present invention relates to the application of geminals zwitterionics liquids based on bis-N-alkyl or bis-N-alkenyl or N-cycloalkyl or N-aryl bis-beta aminoacids or its salts thereof as wettability modifiers of rocks such as limestone, dolomite, sand, quartz or heterogeneous lithologies, in the presence of brines with high content of divalent ions such as calcium, magnesium, barium and strontium, high temperature and pressure in processes of enhanced oil recovery. Wettability modifier comprises a geminal zwitterionic liquid based on bis-N-alkyl or bis-N-alkenyl or N-cycloalkyl or N-aryl bis-beta aminoacids or its salts, using as solvent distilled or brine with a high content of divalent ions such as calcium and magnesium or organic solvents compounds derived from alcohols like methanol, ethanol, isopropanol or mixtures thereof, or aromatic as isomers of xylene, toluene, or diesel, gasoline or mixtures thereof.	11-07-2013

Simón Méndez Ferrer, Madrid ES

Patent application number	Description	Published
20130022582	MULTIPOTENT NESTIN-POSITIVE CELLS - The present invention relates to the use of at least one isolated multipotent stem cell for maintaining haematopoiesis in vitro, in which said multipotent stem cell is preferably a mesenchymal stem cell or, more preferably, said mesenchymal stem cell is a mesenchymal stem cell capable of expressing the nestin protein. The present invention also relates to an isolated cell population of adult nestin-positive mesenchymal cells from a mammal, including humans, to the use thereof for producing a drug for maintaining haematopoiesis in a mammal, for the prevention and/or treatment of at least one disease associated with a malfunction in maintaining haematopoiesis in a mammal, and for maintaining and expanding adult haematopoietic stem cells of said mammal, including a human. Furthermore, the present invention also relates to a method for maintaining haematopoiesis in vitro or to a method for evaluating the haematopoietic capacity of a mammal.	01-24-2013

Simón Menendez- Bravo, Sante Fe AR

Patent application number	Description	Published
20160053271	Engineered Organisms for Production of Novel Lipids - The present disclosure provides engineered microorganisms, engineered biosynthetic pathways, methods of producing lipid compounds using genetically engineered microorganisms, and the products synthesized by those organisms. In particular, the disclosure provides genetically engineered microorganisms for the production of multi-methyl branched fatty acids (MMBFAs) and MMBFA esters (wax esters) derived from these fatty acids. In addition, the disclosure provides methods for producing acylglycerols with one of more of their acyl substituents being an MMBFA, and methods for producing alcohols derived from MMBFAs (fatty alcohols).	02-25-2016

Simón Salosny Hübner, Santiago CL

Patent application number	Description	Published
20140030387	MICRO-ENCAPSULATED ANIMAL PROTEIN CONCENTRATE - The invention relates to an animal protein concentrate, fit for the human consumption, elaborated on basis of a fish protein. More specifically, this invention relates with micro-particle matrix or multicore of fish protein and gelatin, optionally coated, fit for the elaboration of processed food for human consumption.	01-30-2014

Simón Schwartz Navarro, Cardedeu ES

Patent application number	Description	Published
20150190530	FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS - The invention relates to conjugates in which a sterol is functionalized by an ether bond with a water-soluble polymer to which a guiding ligand is bound. These conjugates improve the physico-chemical and delivery properties of their carrying vesicles, making these more stable, homogeneous and effective. A method for their preparation, a pharmaceutical composition containing said liposomes, and their therapeutic use are described as well.	07-09-2015

Simón Schwartz Navarro, Barcelona ES

Patent application number	Description	Published
20130096024	METHOD FOR DETECTING THE SUSCEPTIBILITY TO DEVELOP ADVERSE SIDE EFFECTS RELATED TO BIOIMPLANTS - An in vitro method for the analysis of the genetic predisposition of an individual to develop adverse effects related to non-metallic materials implanted into the body. The method comprises determining if in a biological sample from an individual there is/are present the antigen/s HLA-B*08 and/or HLA-DRB1*03 of the major histocompatibility complex. The use of a kit for carrying out the determination and the use of the antigens as genetic markers is also disclosed.	04-18-2013

Simón Schwartz Navarro, Cardedeu(barcelona) ES

Patent application number	Description	Published
20100107699	Method and system for producing an infrared transmitting fiber - The invention relates to a method for producing an infrared transmitting fiber (	05-06-2010

Simón Schwartz Navarro, Cardedeu(barcelona) ES

Patent application number	Description	Published
20100107699	Method and system for producing an infrared transmitting fiber - The invention relates to a method for producing an infrared transmitting fiber (	05-06-2010

Simón Schwartz Navarro, Barcelona ES

Patent application number	Description	Published
20130096024	METHOD FOR DETECTING THE SUSCEPTIBILITY TO DEVELOP ADVERSE SIDE EFFECTS RELATED TO BIOIMPLANTS - An in vitro method for the analysis of the genetic predisposition of an individual to develop adverse effects related to non-metallic materials implanted into the body. The method comprises determining if in a biological sample from an individual there is/are present the antigen/s HLA-B*08 and/or HLA-DRB1*03 of the major histocompatibility complex. The use of a kit for carrying out the determination and the use of the antigens as genetic markers is also disclosed.	04-18-2013